Article

The urinary proteome of individuals with a family history of frontotemporal dementia (FTD) but without known mutations differs from that of healthy controls

2024-11-26

Abstract excerpt

Frontotemporal dementia (FTD) is a common type of neurodegenerative dementia and the primary cause of dementia in individuals under 65 years old. Current studies typically consider family members carrying relevant gene mutations as genetic risk populations, while individuals with a family history of FTD but without known mutations are sometimes included as healthy controls in research, with their potential pathoph...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ae29bad8-3024-518a-8ca3-54f4c6ac7516
DOI: 10.1101/2024.11.25.625321

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The urinary proteome of individuals with a family history of frontotemporal dementia (FTD) but without known mutations differs from that of healthy controlsDOI 10.1101/2024.11.25.625321Read

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.Semantic proximity Read

Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypesSemantic proximity Read

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of ProteomicsSemantic proximity Read

Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later lifeSemantic proximity Read

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in DementiaSemantic proximity Read

Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal DementiaSemantic proximity Read

Urinary proteome profiling for stratifying patients with familial Parkinson’s diseaseSemantic proximity Read

Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia riskSemantic proximity Read

Fluid biomarkers in frontotemporal dementia: past, present and futureSemantic proximity Read

Urinary proteome profiling for stratifying patients with familial Parkinson's disease.Semantic proximity Read

Network Analysis of the Cerebrospinal Fluid Proteome Reveals Shared and Unique Differences Between Sporadic and Familial Forms of Amyotrophic Lateral SclerosisSemantic proximity Read

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature reviewSemantic proximity Read